These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39109998)

  • 1. Exploring the Mediating Role of Multiple Organ Dysfunction in Sepsis-Induced Disseminated Intravascular Coagulation and Its Impact on Worsening Prognosis.
    Wang G; Hao C; Yao S; Wang Y; Xu Z; Zhao H; An Y
    Clin Appl Thromb Hemost; 2024; 30():10760296241271358. PubMed ID: 39109998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
    Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
    Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems.
    Saito S; Uchino S; Hayakawa M; Yamakawa K; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Sasabuchi Y;
    J Crit Care; 2019 Apr; 50():23-30. PubMed ID: 30471557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the diagnostic value of coagulation markers and coagulation function indices on the occurrence of DIC in sepsis and its prognosis.
    Fang X; Fu W; Xu L; Qiu Y
    Allergol Immunopathol (Madr); 2024; 52(5):65-72. PubMed ID: 39278853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
    Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
    Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Changes in the Sequential Organ Failure Assessment Score Among Patients With Sepsis-Induced Disseminated Intravascular Coagulation.
    Mochizuki K; Mori K; Nakamura Y; Uchimido R; Kamijo H; Takeshige K; Nitta K; Imamura H
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):332S-339S. PubMed ID: 30486666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).
    Iba T; Maier CL; Tanigawa T; Levy JH
    Sci Rep; 2023 Dec; 13(1):22502. PubMed ID: 38110515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yamakawa K; Ogura H; Fujimi S; Morikawa M; Ogawa Y; Mohri T; Nakamori Y; Inoue Y; Kuwagata Y; Tanaka H; Hamasaki T; Shimazu T
    Intensive Care Med; 2013 Apr; 39(4):644-52. PubMed ID: 23361628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of the simplified JSTH score criteria in the early diagnosis of sepsis-associated disseminated intravascular coagulation].
    Wang YY; Wan XH; Huang QQ; Wang G; Wan LJ; Liu OY
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):837-841. PubMed ID: 32234155
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis.
    Slatnick LR; Thornhill D; Deakyne Davies SJ; Ford JB; Scott HF; Manco-Johnson MJ; Warren BB
    J Pediatr; 2020 Oct; 225():198-206.e2. PubMed ID: 32553867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
    Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
    Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study.
    Ding R; Wang Z; Lin Y; Liu B; Zhang Z; Ma X
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):551-558. PubMed ID: 30015646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.